Masimo Corporation  

(Public, NASDAQ:MASI)   Watch this stock  
Find more results for masi
39.67
-0.39 (-0.97%)
Sep 4 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 39.41 - 40.69
52 week 20.48 - 46.00
Open 39.61
Vol / Avg. 408,266.00/399,695.00
Mkt cap 2.04B
P/E 28.09
Div/yield     -
EPS 1.41
Shares 50.99M
Beta 0.96
Inst. own 84%
Oct 27, 2015
Q3 2015 Masimo Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Sep 18, 2015
Masimo Corp at Morgan Stanley Healthcare Conference - 11:05AM EDT - Add to calendar
Aug 4, 2015
Q2 2015 Masimo Corp Earnings Call - Webcast
Aug 4, 2015
Q2 2015 Masimo Corp Earnings Release
Jun 9, 2015
Masimo Corp at Goldman Sachs Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Jul '15) 2015
Net profit margin 12.01% 12.68%
Operating margin 17.88% 17.64%
EBITD margin - 18.07%
Return on average assets 12.94% 14.82%
Return on average equity 25.56% 22.93%
Employees 1,200 -
CDP Score - -

Address

52 Discovery
IRVINE, CA 92618-3105
United States - Map
+1-949-2977000 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Masimo Corporation is a global medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company's core business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive optical blood constituent monitoring, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and optical gas monitoring. In addition, the Company offers Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. The Company also has the Patient SafetyNet remote patient surveillance monitoring system, which allows up to 80 patients to be monitored simultaneously through a central station or remotely by care providers through their pagers or smart phones.

Officers and directors

Joe E. Kiani Chairman of the Board, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
Mark P. de Raad Chief Financial Officer, Executive Vice President - Finance
Age: 55
Bio & Compensation  - Reuters
Jon Coleman President - Worldwide Sales, Professional Services and Medical Affairs
Age: 51
Bio & Compensation  - Reuters
Rick Fishel President, Worldwide OEM Business & Blood Management
Age: 57
Bio & Compensation  - Reuters
Anand Sampath Chief Operating Officer
Age: 48
Bio & Compensation  - Reuters
Yongsam Lee Executive Vice President, Chief Information Officer
Age: 50
Bio & Compensation  - Reuters
Tom McClenahan Executive Vice President, General Counsel, Corporate Secretary
Age: 42
Bio & Compensation  - Reuters
Paul Jansen Executive Vice President - Business Development
Age: 44
Bio & Compensation  - Reuters
David J. Van Ramshorst Chief Accounting Officer
Age: 54
Bio & Compensation  - Reuters
Steven J. Barker M.D., Ph.D. Director
Age: 70
Bio & Compensation  - Reuters